Jordi Salas-Salvadó, MD, PhD 

Currently Director of the Catalan Nutrition Centre (CCNIEC), President of the World Forum for Nutrition Research and Dissemination (INC), and a member of the expert panel of the Diabetes and Nutrition Study Group (DSNG). Prof Salas’ research has focused on human clinical trials to evaluate the effects of foods, dietary compounds and dietary patterns on obesity, diabetes, metabolic syndrome and cardiovascular disease. Since 2005, he has been one of the principal investigators of the PREDIMED study (n=7447 participants) and is currently the coordinator and chairman of the steering committee of the PREDIMED-Plus study (n=6874 participants), two large clinical trials for the primary prevention of cardiovascular disease and mortality. PREDIMED-Plus is a multi-collaborative project involving 30 research groups and has received national, European, Canadian and US grants. Through all these projects and collaborations, the group has developed skills in precision medicine using different OMIC methodologies, in particular metabolomics and metagenomics, which we are now implementing in epidemiological and clinical studies. He is also involved in two prospective national and international cohort studies: CORALS (children followed for 10 years) and LEDFERTYL (men of reproductive age). He has published more than 850 scientific articles with more than 110,000 citations and a Google Schollar H-index of 153, has published 14 books and has supervised 42 PhD students. Has been named one of the world’s most influential researchers by Clarivate Analytics and Standford University.